Bruce Wendel serves as Executive at Abraxis BioScience, Inc., where they oversee executive responsibilities. Since joining the company, Bruce Wendel has executed 15 insider transactions totaling $54.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 16, 2021 involved receiving (via award) 347,572 shares valued at $0.
Bruce Wendel currently holds 352,655 shares of Abraxis BioScience, Inc. (ABII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bruce Wendel has been a net seller of ABII stock. They have purchased $26.3K and sold $28.2K worth of shares.
Bruce Wendel's most recent insider trade was on Feb 16, 2021, when they sold 347,572 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.87 |
| Discretionary |
| Dec 22, 2020 | GTBP | $3.8K | Purchase | 441 | $8.73 | Discretionary |
| Nov 16, 2020 | GTBP | $10.3K | Purchase | 3,268 | $3.14 | Discretionary |
| Oct 15, 2010 | ABII | $0 | Disposition | 119,784 | $N/A | Discretionary |
| Oct 15, 2010 | ABII | $0 | Award | 50,000 | $N/A | Discretionary |
| Mar 15, 2010 | ABII | $0 | Award | 74,375 | $N/A | Discretionary |
| Mar 1, 2010 | ABII | $12.0K | Payment | 367 | $32.67 | Discretionary |
| Jan 15, 2010 | ABII | $9.8K | Payment | 239 | $41.17 | Discretionary |
| Nov 10, 2009 | ABII | $28.2K | Sale | 797 | $35.42 | Discretionary |
| Mar 2, 2009 | ABII | $19.3K | Payment | 329 | $58.54 | Discretionary |
| Mar 2, 2009 | ABII | $0 | Option Exercise | 920 | $N/A | Discretionary |
| Feb 3, 2009 | ABII | $11.0K | Payment | 156 | $70.40 | Discretionary |
| Feb 3, 2009 | ABII | $0 | Award | 1,446 | $N/A | Discretionary |
| Nov 5, 2008 | ABII | $0 | Award | 3,678 | $N/A | Discretionary |